Immunohistochemical analysis of B7-H3 expression in patients with lung cancer following various anti-cancer treatments-Reference-Cited by-同舟云学术

Immunohistochemical analysis of B7-H3 expression in patients with lung cancer following various anti-cancer treatments

Published:2023-04 Issue:2 Volume:41 Page:356-364
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Omori Shota,Muramatsu Koji,Kawata Takuya,Miyawaki Eriko,Miyawaki Taichi,Mamesaya Nobuaki,Kawamura Takahisa,Kobayashi Haruki,Nakashima Kazuhisa,Wakuda Kazushige,Ono Akira,Kenmotsu Hirotsugu,Naito Tateaki,Murakami Haruyasu,Sugino Takashi,Takahashi Toshiaki

Funder

Daiichi Sankyo Co., Ltd., Tokyo, Japan.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10637-023-01353-8.pdf

Reference30 articles.

1. Reck M, Rodríguez-Abreu D, Robinson AG et al (2016) Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med 375(19):1823–1833

2. Gandhi L, Rodríguez-Abreu D, Gadgeel S et al (2018) Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N Engl J Med 378(22):2078–2092

3. Paz-Ares L, Luft A, Vicente D et al (2018) Pembrolizumab plus chemotherapy for squamous non-small-cell lung cancer. N Engl J Med 379(21):2040–2051

4. Horn L, Mansfield AS, Szczęsna A et al (2018) First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer. N Engl J Med 379(23):2220–2229

5. Paz-Ares L, Dvorkin M, Chen Y et al (2019) Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Lancet 394(10212):1929–1939

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment of a pathomic-based machine learning model to predict CD276 (B7-H3) expression in colon cancer;Frontiers in Oncology;2024-01-08

2. New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3;Vaccines;2024-01-05